DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease (2023)
- Authors:
- USP affiliated authors: FERREIRA, LEONARDO LUIZ GOMES - IFSC ; ANDRICOPULO, ADRIANO DEFINI - IFSC ; OLIVEIRA, ALDO SENA DE - IFSC
- Unidade: IFSC
- DOI: 10.2174/0929867329666220620162018
- Subjects: DOENÇA DE ALZHEIMER; INIBIDORES DE ENZIMAS
- Keywords: Alzheimer's disease; Neurodegeneration; Protein kinases; Enzyme kinetics; DYRK1A inhibitors; Molecular docking
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Current Medicinal Chemistry
- ISSN: 0929-8673
- Volume/Número/Paginação/Ano: v. 30, n. 6, p. 669-688, 2023
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
SOUZA, Márcia Maria de et al. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, v. 30, n. 6, p. 669-688, 2023Tradução . . Disponível em: https://doi.org/10.2174/0929867329666220620162018. Acesso em: 28 dez. 2025. -
APA
Souza, M. M. de, Cenci, A. R., Teixeira, K. F., Machado, V., Mendes, M. C. G., Gonçalves, A. E., et al. (2023). DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease. Current Medicinal Chemistry, 30( 6), 669-688. doi:10.2174/0929867329666220620162018 -
NLM
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2025 dez. 28 ] Available from: https://doi.org/10.2174/0929867329666220620162018 -
Vancouver
Souza MM de, Cenci AR, Teixeira KF, Machado V, Mendes MCG, Gonçalves AE, Dalmagro AP, Cazarin CA, Ferreira LLG, Oliveira AS de, Andricopulo AD. DYRK1A inhibitors and perspectives for the treatment of Alzheimer's disease [Internet]. Current Medicinal Chemistry. 2023 ; 30( 6): 669-688.[citado 2025 dez. 28 ] Available from: https://doi.org/10.2174/0929867329666220620162018 - Molecular docking and quantum studies of lawsone dimers derivatives: new investigation of antioxidant behavior and antifungal activity
- Quantitative structure-activity relationships for structurally diverse chemotypes having anti-Trypanosoma cruzi activity
- Novel brominated vinylic fatty acids effectively inhibit the leishmania topoisomerase IB enzyme mediated by halogen bond formation
- 3D QSAR studies for a series of Trypanosoma cruzi dehydrogenase inhibitors
- Saúde e bem-estar
- Cancer estimates in Brazil reveal progress for the most lethal malignancies [Editorial]
- Evaluation of pyrazolines as anti-alzheimer's agents: DFT, molecular docking, enzyme inhibition and pharmacokinetic studies
- Synthesis and in vitro leishmanicidal activity of novel n-arylspermidine derivatives
- Structure-activity relationships of sulfonamides derived from carvacrol as new agents for the treatment of Alzheimer's disease
- World chagas disease day and the new road map for neglected tropical diseases. [Editorial]
Informações sobre o DOI: 10.2174/0929867329666220620162018 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
PROD033747_3111047.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
